Nuvasive Specialized Orthopedics, Inc.
2560 General Armistead Ave, Audubon, PA, US
Registered product codes
23 product codes
Recent MDR events
1,406 on file
- PRECICE® INTRAMEDULLARY LIMB LENGTHENING SYSTEMMay 27, 2026Malfunction3006179046-2026-00107
- PRECICE® INTRAMEDULLARY LIMB LENGTHENING SYSTEMMay 18, 2026Malfunction3006179046-2026-00106
- PRECICE® BONE TRANSPORT SYSTEMMar 18, 2026Malfunction3006179046-2026-00105
- PRECICEMar 11, 2026Malfunction3006179046-2026-00104
- PRECICE® INTRAMEDULLARY LIMB LENGTHENING SYSTEMFeb 17, 2026Malfunction3006179046-2026-00103
- PRECICE® INTRAMEDULLARY LIMB LENGTHENING SYSTEMFeb 13, 2026Malfunction24332295
- PRECICE® INTRAMEDULLARY LIMB LENGTHENING SYSTEMFeb 9, 2026Malfunction3006179046-2026-00102
- PRECICE® BONE TRANSPORT SYSTEMJan 23, 2026Malfunction3006179046-2026-00101
- PRECICE® INTRAMEDULLARY LIMB LENGTHENING SYSTEMJan 9, 2026Malfunction3006179046-2026-00100
- PRECICE® BONE TRANSPORT SYSTEMDec 22, 2025Malfunction3006179046-2025-00138
Recalls
11 on file
- Open, ClassifiedNov 21, 2024
Due to potential issues with design, manufacturing and documentation issues related to the validation of the affected products/devices.
View FDA record ↗ - Open, ClassifiedDec 14, 2022
During accelerated shelf-life extension studies it was noted that the final packaging was experiencing a potential of failure of the sterile packaging barrier which could result in a hazardous situation where the device is no longer sterile.
View FDA record ↗ - Open, ClassifiedDec 1, 2021
The Instructions for Use have been updated to include: (1) Clarification that the device is intended for use only in patients 18 years and older, (2) That patients should weigh 50 lbs. or more while undergoing treatment, and (3) That no more than two devices should be implanted at a time.
View FDA record ↗ - Open, ClassifiedApr 5, 2021
Due to not having the full complement of biological assessments for all potential patients and as a result the devices are not indicated for use in individuals under the age of 18 years old.
View FDA record ↗ - Open, ClassifiedApr 5, 2021
Due to not having the full complement of biological assessments for all potential patients and as a result the devices are not indicated for use in individuals under the age of 18 years old.
View FDA record ↗ - Open, ClassifiedApr 5, 2021
Due to not having the full complement of biological assessments for all potential patients and as a result the devices are not indicated for use in individuals under the age of 18 years old.
View FDA record ↗ - Open, ClassifiedMar 30, 2021
Due to complaints of adverse events potentially related to biological safety. The complaints included report of pain and bony abnormalities at the interface between the telescoping nail segments.
View FDA record ↗ - Open, ClassifiedMar 30, 2021
Due to complaints of adverse events potentially related to biological safety. The complaints included report of pain and bony abnormalities at the interface between the telescoping nail segments.
View FDA record ↗ - Open, ClassifiedMar 30, 2021
Due to complaints of adverse events potentially related to biological safety. The complaints included report of pain and bony abnormalities at the interface between the telescoping nail segments.
View FDA record ↗ - Open, ClassifiedUnknown
During explantation, standard removal tools can generate sufficient forces to cause distal plug to disassociate from the bone transport system.
View FDA record ↗
Compliance history
Matched by FEI 3006179046.
FDA inspections
1 on file
- Voluntary Action Indicated (VAI)May 6, 2024
Compliance: Devices · Citations posted
Inspection citations
12 on file
Top cited requirements
Compare to industry ↗21 CFR 820.30(g)Design validation - production units
221 CFR 803.50(a)(2)Individual Report of Malfunction
121 CFR 820.25(b)Training - Lack of or inadequate procedures
121 CFR 820.30(d)Design output - Lack of or inadequate procedures
121 CFR 820.30(f)Design verification - output does not meet input requirement
121 CFR 820.30(h)Design transfer - Lack of or inadequate procedures
1
- 21 CFR 803.50(a)(2)May 6, 2024
Individual Report of Malfunction
- 21 CFR 820.25(b)May 6, 2024
Training - Lack of or inadequate procedures
- 21 CFR 820.30(d)May 6, 2024
Design output - Lack of or inadequate procedures
- 21 CFR 820.30(f)May 6, 2024
Design verification - output does not meet input requirement
- 21 CFR 820.30(g)May 6, 2024
Design validation - production units
- 21 CFR 820.30(g)May 6, 2024
Design Validation - Risk analysis not performed/inadequate
- 21 CFR 820.30(h)May 6, 2024
Design transfer - Lack of or inadequate procedures
- 21 CFR 820.30(i)May 6, 2024
Design changes - Lack of or Inadequate Procedures
- 21 CFR 820.75(a)May 6, 2024
Lack of or inadequate process validation
- 21 CFR 820.86May 6, 2024
Acceptance status
- 21 CFR 820.90(a)May 6, 2024
Nonconforming product, Lack of or inadequate procedures
- 21 CFR 820.100(a)May 6, 2024
Lack of or inadequate procedures
Compliance actions
0 on file
No warning letters or injunctions on file for this FEI number.
Import refusals
0 on file
No import refusals on file for this FEI number.